Intero Biosystems wins TechCrunch Startup Battlefield 2026

TechCrunch reports that Intero Biosystems beat 199 other Startup Battlefield companies to win $100,000 at Disrupt 2026. The Denver startup develops tiny human intestinal organoids—lab-grown tissue that mimics the gut—to study how drugs and other compounds might affect people before they are tested in humans. It sells a testing product called GastroScreen. Apate, which uses AI agents to bait scammers and gather fraud intelligence, finished runner-up.